Symfony vs Vivity in Dim Light

Inclusion criteria

• Subject is undergoing bilateral lens extraction with implantation of an EDOF IOL with a target refraction of plano OU.
• Gender: Males and Females.
• Age: 50 years and older.
• Willing and able to provide written informed consent for participation in the study
• Willing and able to comply with scheduled visits and other study procedures.
• Scheduled to undergo standard cataract surgery in both eyes, with 1 to 30 days between surgeries.
• Potential postoperative visual acuity of 0.2 logMAR (20/32 Snellen) or better in both eyes.

Exclusion criteria

• Severe preoperative ocular pathology
• Uncontrolled diabetes.
• Use of any systemic or topical drug known to interfere with visual performance.
• Contact lens use during the active treatment portion of the trial.
• Any concurrent infectious/non-infectious conjunctivitis, keratitis, or uveitis.
• Clinically significant corneal dystrophy.
• Corneal irregularities potentially affecting visual acuity (i.e., keratoconus, corneal opacities.
• History of chronic intraocular inflammation.
• History of retinal detachment.
• Pseudoexfoliation syndrome or any other condition that has the potential to weaken the zonules.
• Previous intraocular surgery.
• Previous corneal refractive surgery (i.e., LASIK, PRK, RK).
• Subject who declined any type of presbyopia correcting IOL due to concerns with visual disturbances (i.e., halos)
• Previous keratoplasty
• Severe dry eye
• Pupil abnormalities
• Subject who may reasonably be expected to require a secondary surgical intervention at any time during the study (other than YAG capsulotomy, i.e., LASIK)
• Any clinically significant, serious, or severe medical or psychiatric condition that may increase the risk associated with study participation or may interfere with the interpretation of study results.
• Participation in (or current participation) any ophthalmic investigational drug or ophthalmic device trial within the previous 30 days prior to the start date of this trial.